Life Sciences Trend Analysis 2015

South Korea

About Us

The following statistical information has been obtained from Biotechgate. Biotechgate is a global, comprehensive, Life Sciences database encompassing the Biotechnology,Pharmaceutical and Medical Device industries. www.biotechgate.com

Biotechgate is owned and operated by Venture Valuation AG, a Zurich based company specializing in independent assessment and valuation of technology-driven companies in high growth industries, such as the Life Sciences (Biotech, Pharma, Medtech), ICT, high-tech, Nanotech, Cleantech and Renewable energy. www.venturevaluation.com

Status of the Sector 7

South Korea 2013 Statistics 2014 Statistics

Total Biotech Companies 221 196

Biotech - Therapeutics 60 41

Biotech - R&D Services 66 65

Biotech - Other 95 90

Percentage of SME's 92% 78%

Percentage of Publicly Owned Companies 11% 13%

Financing/Capital Raised USD 19,810 (31.12.2013)

USD 84,922 (31.10.2014)

Licensing Opportunities 99 103

Key Activities of Biotechnology Companies

Historical DataSubsector 2013 2014AgroBio 5% 4%

Environment 6% 5%

Contract Research & Manufacturing 5% 6%

Diagnostics and Analytical Services 11% 11%

Food & Nutraceuticals 12% 14%

Other Services and Suppliers 22% 21%

Therapeutics 13% 11%

Bioinformatics and Bioelectronics 2% 3%

Cosmetics 6% 9%

Drug Delivery 3% 3%

Gemomics and Proeomics 7% 7%

Industrial Biotechnology 3% 3%

Veterinary 5% 4%

Company Ownership

Historical Data

Subsector 2013 2014

Private/ Independent 87% 81%

Public 11% 13%

Subsidiary 2% 6%

Subsidiary6%

Public14%

Private / independent81%

2014 Data

Sources of Company Foundations

Historical DataCompany Foundation 2013 2014

Undisclosed 31% 11%

Independent foundation 56% 76%

Spin-off from company 3% 1%

Spin-off from public institution / NPO 2% 2%

Spin-off from university 1% 1%

Subsidiary 2% 5%Other 5% 5%

2014 Data

Undisclosed11%

Independent foundation76%

Spin-off from com-pany1%

Spin-off from

public institu-tion / NPO2%

Spin-off from

univer-sity1%

Sub-sidiary

5% Other5%

Number of Employees

Historical DataNo. of Employees 2013 20141-10 4% 9%11-50 50% 35%51-200 8% 48%Greater than 200 38% 9%

1-10:9%

11-50:35%

51-200:48%

200+9%

2014 Data

Products in the Pipeline

Preclinical

Phase I

Phase II

Phase III

0tan28a566028 0tan19a566019 0tan9a56609 0tan29a566029 0tan19a566019

0tan25a566025

0tan19a566019

0tan11a566011

0tan8a56608

0tan1a56601

0tan18a566018

0tan20a566020

0tan13a566013

2014

2013

No. of Products

Dev

elop

men

t Pha

se

Financing Rounds in S. Korea & 3 Major Financing Rounds

Financing for 2013/2014 Private Biotech CompaniesMajor Financings in 2013/2014 Sector KRW (M) USD

Legochem Biosciences, Inc. Biotech – Therapeutics & Diagnostics 21700 19171

ISU Abxis Co., Ltd Biotech – Therapeutics & Diagnostics 20000 18258

CrystalGenomics Biotech – Therapeutics & Diagnostics 13000 11868

0tan28a5665280tan30a566530 0tan1a56651 0tan2a56652 0tan3a566530tan28a566028

0tan6a56736

0tan16a568716

0tan25a570125

0tan6a57156

0tan15a572815

0tan28a566028

0tan29a566029

0tan1a56601

0tan2a56602

0tan3a56603

Total Financing Value (KRW M) No. of Funding Rounds

Year

Tota

l Fin

anci

ng V

alue

(KRW

M)

No.

of F

undi

ng R

ound

s

About Biotechgate

Biotechgate contains over 30’000 high quality company profiles which include company descriptions, contact information, product pipeline information, financing rounds and management details. Profiles are regularly updated by the companies themselves, as well as by an experienced database team, to ensure the accuracy and relevance of the data.

To register for free or learn more about the different subscription options, please visit www.biotechgate.com.

Terms of Use

The “South Korea Life Sciences Trend Analysis” is based on data entered in the Biotechgate Database available at www.biotechgate.com. The statistics and graphs in this presentation are based on figures and information entered in this database and we do not guarantee any accuracy hereof.

The use of the figures and graphs provided in this report is free of charge for any presentations as long as www.biotechgate.com is clearly cited as the source. For all other uses please contact us for terms and conditions.

Biotechgatec/o Venture Valuation VV AGKasernenstrasse 11 +41 (43) 321 86 608004 Zurich info@venturevaluation.comSwitzerland www.venturevaluation.com